Mit Patel
11 Papers
14 Citations
Mit Patel is an academic researcher. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 1, co-authored 1 publications.
Chat about Author
Papers
SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters
Peter Halfmann,Shun Iida,Kiyoko Iwatsuki-Horimoto,Tadashi Maemura,Maki Kiso,Suzanne M. Scheaffer,Tamarand L. Darling,Astha Joshi,Samantha Loeber,Gagandeep Singh,Stephanie L. Foster,Baoling Ying,James Brett Case,Zhenlu Chong,Bradley M. Whitener,Juan I. Moliva,Katharine Floyd,Michiko Ujie,Noriko Nakajima,Mutsumi Ito,R. Wright,Ryuta Uraki,Prajakta Warang,Matthew Gagne,Rongxiu Li,Yuko Sakai-Tagawa,Yanan Liu,Deanna Larson,Jorge E. Osorio,Juan P. Hernández-Ortiz,Amy R. Henry,Karl A Ciuoderis,Kelsey Florek,Mit Patel,Abby E. Odle,Lok-Yin Roy Wong,Allen C. Bateman,Zhongde Wang,Venkata Viswanadh Edara,John Franks,Trushar Jeevan,Thomas P. Fabrizio,Jennifer DeBeauchamp,Lisa Kercher,Patrick Seiler,Ana S. Gonzalez-Reiche,Emilia Mia Sordillo,Lauren A. Chang,Harm van Bakel,Viviana Simon,Bremy Alburquerque,Hala Alshammary,Angela Amoako,Shiraz Aslam,Radhika N. Banu,Cecilia Cognigni,Marlene Espinoza-Moraga,K. Farrugia,Adriana van de Guchte,Z. Khalil,Manon Laporte,Ignacio Mena,Alberto Paniz-Mondolfi,Jose Polanco,A.A. “Sonny” Rooker,L. Sominsky,Daniel C. Douek,Nancy J. Sullivan,Larissa B. Thackray,Hiroshi Ueki,Seiya Yamayoshi,Masaki Imai,Stanley Perlman,Richard J. Webby,Robert A. Seder,Mehul S. Suthar,Adolfo García-Sastre,Michael Schotsaert,Tadaki Suzuki,Adrianus C. M. Boon,Michael S. Diamond,Yoshihiro Kawaoka +81 more
TL;DR: In this paper , the authors evaluated the ability of several B.1.529 isolates to cause infection and disease in immunocompetent and human ACE2 (hACE2)-expressing mice and hamsters.
mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits similar B cell expansion, neutralizing responses, and protection from Omicron
Matthew Gagne,Juan I. Moliva,Kathryn E. Foulds,Shayne Andrew,Barbara J. Flynn,Anne P. Werner,Danielle A Wagner,I-Ting Teng,Bob C. Lin,Christopher Brooks Moore,Nazaire Jean-Baptiste,Robin E. Carroll,Stephanie L. Foster,Mit Patel,Madison Ellis,Venkata Viswanadh Edara,Nahara Vargas Maldonado,Mahnaz Minai,Lauren McCormick,Christopher Cole Honeycutt,Bianca M. Nagata,Kevin W. Bock,Caitlyn N. M. Dulan,Jamilet Cordon,Dillon R. Flebbe,John Paul Todd,Elizabeth McCarthy,Laurent Pessaint,Alex Van Ry,Brandon Narvaez,Daniel Valentin,Anthony Cook,Alan Dodson,Katelyn Steingrebe,Saule Nurmukhambetova,Sucheta Godbole,Amy R. Henry,Farida Laboune,Jesmine Roberts-Torres,Cynthia G. Lorang,Shivani G. Amin,Jessica F. Trost,M. Naisan,Manjula Basappa,J. B. Willis,Lingshu Wang,Wei Shi,Nicole A. Doria-Rose,Yi Zhang,Eun Sung Yang,Kwanyee Leung,Sijy O'Dell,R. Schmidt,Adam S. Olia,Cuiping Liu,Darcy R. Harris,Gwo-Yu Chuang,Guillaume Stewart-Jones,Isabella Renzi,Yen-Ting Lai,Agata Malinowski,Kai Wu,John R. Mascola,Andrea Carfi,Peter D. Kwong,Darin K. Edwards,Mark A. Lewis,Hanne Andersen,Kizzmekia S. Corbett,Martha Nason,Adrian B. McDermott,Mehul S. Suthar,Ian N. Moore,Mario Roederer,Nancy J. Sullivan,Daniel C. Douek,Robert A. Seder +76 more
TL;DR: In this article , the authors showed that boosting with Omicron-matched vaccines would enhance protection, but it is unclear whether boosting with omicron matched vaccines would improve protection.
217
Interdomain Stabilization Impairs CD4 Binding and Improves Immunogenicity of the HIV-1 Envelope Trimer.
Peng Zhang,Jason Gorman,Hui Geng,Qingbo Liu,Yin Lin,Yaroslav Tsybovsky,Eden P. Go,Barna Dey,Tsion Andine,Alice Kwon,Mit Patel,Deepali Gururani,Ferzan Uddin,Christina Guzzo,Raffaello Cimbro,Huiyi Miao,Krisha McKee,Gwo-Yu Chuang,Loïc Martin,Francesca Sironi,Mauro S. Malnati,Heather Desaire,Edward A. Berger,John R. Mascola,Michael A. Dolan,Peter D. Kwong,Paolo Lusso +26 more
TL;DR: Interdomain stabilization provides a widely applicable template for the design of Env-based HIV-1 vaccines and elicited neutralizing antibodies against tier-2 viruses with a repaired glycan shield regardless of treatment with a functional CD4 mimic.
45
Immunogenicity of NVX-CoV2373 heterologous boost against SARS-CoV-2 variants
Kirsten E. Lyke,Robert L. Atmar,Clara P Dominguez Islas,Christine M. Posavad,Meagan E. Deming,Angela Branche,Christine Johnston,Hana M. El Sahly,Srilatha Edupuganti,Mark J. Mulligan,Lisa A. Jackson,Richard E. Rupp,Christina A. Rostad,Rhea N. Coler,Martin Bäcker,Angelica Kottkamp,T. Mariya Babu,David M Dobrzynski,Judith M. Martin,Rebecca C. Brady,Robert W. Frenck,Kumaravel Rajakumar,Karen L. Kotloff,Nadine Rouphael,Daniel W. Szydlo,Janet I. Archer,Sonja Crandon,Brian P. Ingersoll,Amanda Eaton,Elizabeth R. Brown,M. Juliana McElrath,Kathleen M. Neuzil,David S. Stephens,Diane J. Post,Bob C. Lin,L. R. Serebryannyy,John H. Beigel,David C. Montefiori,Paul C. Roberts,Evan D. Anderson,Megan A. Berman,Kristen W. Cohen,Stephen D De Rosa,Michelle Dickey,Madison L Ellis,Ann R. Falsey,Andrew B. Fleming,Katharine Floyd,Stephanie L Foster,Daniel S. Graciaa,A.H. Kahn,Satoshi Kamidani,Wendy A. Keitel,Lilin Lai,Sasha E. Larsen,Marina S. Lee,Kelly E. Manning,Kathryn Moore,Gysella Muniz,Seema U Nayak,Asif Noor,Mit Patel,Laura K. Porterfield,Angie Price,Ian Shannon,Timothy R. Shope,Mehul S. Suthar,Anna Wald,Jennifer A. Whitaker +68 more
TL;DR: The use of heterologous protein-based booster vaccines as an acceptable alternative to mRNA or adenoviral-based COVID-19 booster vaccines is supported, as well as prior SARS CoV-2 infection, which was associated with substantially higher baseline PsVNA titers.
18
Loss of Pfizer (BNT162b2) Vaccine-Induced Antibody Responses against the SARS-CoV-2 Omicron Variant in Adolescents and Adults
Sneh Gupta,Grace Mantus,Kelly E. Manning,Madison Ellis,Mit Patel,C. Ciric,Austin Lu,Jackson S. Turner,Jane A. O’Halloran,Rachel M. Presti,Devyani Joshi,Ali H. Ellebedy,Evan J. Anderson,Christina A. Rostad,Mehul S. Suthar,Jens Wrammert +15 more
TL;DR: Comparing the magnitude and breadth of humoral immune responses in adolescents and adults 1 month after the two-dose Pfizer (BNT162b2) vaccination found that adolescents demonstrated more robust binding antibody and neutralization responses against the wild-type SARS-CoV-2 virus spike protein contained in the vaccine.
16